a_controlling_stake	markable_11	Delmed	markable_119
addition	markable_12	resigned_and_were_succeeded	markable_124
pricing	markable_17	a_dialysis_solution_used_in_treating_kidney_diseases	markable_14
chairman	markable_25	Delmed	markable_119
president	markable_27	Delmed	markable_119
chief_executive	markable_28	Delmed	markable_119
a_director	markable_31	Delmed	markable_119
a_consultant	markable_32	Delmed	markable_119
chief_operating_officer	markable_36	Delmed	markable_119
chief_financial_officer	markable_37	Delmed	markable_119
chairman	markable_40	the_company	markable_119
president	markable_52	the_company	markable_119
chief_executive	markable_53	the_company	markable_119
chief_operating_officer	markable_54	the_company	markable_119
the_proposal	markable_83	a_transaction_under_which_Fresenius_would_buy_Delmed_stock_for_cash_to_bring_its_beneficial_ownership_to_between_70_%_and_80_%_of_Delmed_'s_fully_diluted_common_stock	markable_78
addition	markable_118	continue_to_supply	markable_125
distribution_arrangements	markable_120	dialysis_products	markable_112